OptimizeRx 第三季收入 2160 万美元降 17%：净利润 120 万美元、调整后 EBITDA 630 万美元、全年收入指引更新为 8700 万至 9300 万美元
美国马萨诸塞州沃尔瑟姆市 — OptimizeRx 公司 2026 年 11 月 11 日经 GlobeNewswire 发布 2026 年第三季业绩，统计期截至 2026 年 9 月 30 日。该公司为生命科学公司提供触达和互动医疗专业人员与患者的医疗科技方案。以下数字均取自公司官方业绩发布正文。
第三季收入为 2160 万美元，较 2025 年第三季的 2610 万美元下降 17%。按美国通用会计准则，第三季净利润为 120 万美元、每股基本与摊薄收益 0.06 美元，2025 年第三季为净利润 80 万美元、每股 0.04 美元。
非通用会计准则口径方面，第三季非 GAAP 净利润为 380 万美元、摊薄每股 0.20 美元，2025 年第三季为 310 万美元、摊薄每股 0.16 美元。调整后 EBITDA 为 630 万美元，2025 年第三季为 510 万美元。
指引方面，公司更新 2026 财年指引，现预计全年收入 8700 万至 9300 万美元，调整后 EBITDA 指引维持 2100 万至 2500 万美元不变。本稿数字均以 OptimizeRx 官方业绩发布正文为准，媒体预期未作来源。
OptimizeRx Third-Quarter Revenue Falls 17 Percent to 21.6 Million Dollars: Net Income of 1.2 Million Dollars, Adjusted EBITDA of 6.3 Million Dollars, Full-Year Revenue Guidance Updated to 87 to 93 Million Dollars
Waltham, Massachusetts — OptimizeRx Corp. reported its results for the third quarter ended September 30, 2026, via GlobeNewswire on November 11, 2026. The company provides healthcare technology solutions that help life sciences companies reach and engage healthcare professionals and patients. All figures are taken from the body of the company official results release.
Revenue decreased 17 percent to 21.6 million dollars in the third quarter of 2026, compared with 26.1 million dollars in the third quarter of 2025. GAAP net income was 1.2 million dollars, or 0.06 dollars per basic and diluted share, compared with GAAP net income of 0.8 million dollars, or 0.04 dollars per share, in the third quarter of 2025.
On a non-GAAP basis, net income was 3.8 million dollars, or 0.20 dollars per diluted share, compared with 3.1 million dollars, or 0.16 dollars per diluted share, in the prior-year quarter. Adjusted EBITDA was 6.3 million dollars, compared with 5.1 million dollars in the third quarter of 2025.
The company updated its fiscal 2026 guidance and now expects revenue of 87 million to 93 million dollars, with adjusted EBITDA guidance unchanged at 21 million to 25 million dollars. All figures follow the body of the OptimizeRx official results release, and media expectations were not used as a source.
来源：OptimizeRx
发布：GSM·美国（发布链接）
图片来源：图：图中是一家证券交易所的交易大厅与行情屏。图中是交易所大厅的实物照片，为医疗科技业绩题材通用配图，非该公司场所。ehnmark，CC BY 2.0，经Wikimedia Commons。 / Photo: file photo. ehnmark, CC BY 2.0, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story
